These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23508113)

  • 21. Bacterial etiology of empyema thoracis and parapneumonic pleural effusion in Thai children aged less than 16 years.
    Lochindarat S; Teeratakulpisarn J; Warachit B; Chanta C; Thapa K; Gilbert GL; Wangroongsarb Y; Pirçon JY; Van Dyke MK; Liu Y; Hausdorff WP
    Southeast Asian J Trop Med Public Health; 2014 Mar; 45(2):442-54. PubMed ID: 24968687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine.
    Fletcher M; Leeming J; Cartwright K; Finn A;
    Pediatr Infect Dis J; 2006 Jun; 25(6):559-60. PubMed ID: 16732158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era.
    Kendall BA; Dascomb KK; Mehta RR; Mason EO; Ampofo K; Pombo DJ; Pavia AT; Byington CL
    Vaccine; 2011 Nov; 29(49):9123-6. PubMed ID: 22001280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children ≤ 5 years of age with community-acquired pneumonia.
    Marchese A; Esposito S; Coppo E; Rossi GA; Tozzi A; Romano M; Da Dalt L; Schito GC; Principi N
    Microb Drug Resist; 2011 Sep; 17(3):419-24. PubMed ID: 21510746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
    Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
    Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Invasive pneumococcal disease in Poland in 2010].
    Skoczyńska A; Kuch A; Gołebiewska A; Waśko I; Ronkiewicz P; Markowska M; Hryniewicz W
    Pol Merkur Lekarski; 2011 Aug; 31(182):80-5. PubMed ID: 21936342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.
    Rosen JB; Thomas AR; Lexau CA; Reingold A; Hadler JL; Harrison LH; Bennett NM; Schaffner W; Farley MM; Beall BW; Moore MR;
    Clin Infect Dis; 2011 Jul; 53(2):137-43. PubMed ID: 21690620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
    Hicks LA; Harrison LH; Flannery B; Hadler JL; Schaffner W; Craig AS; Jackson D; Thomas A; Beall B; Lynfield R; Reingold A; Farley MM; Whitney CG
    J Infect Dis; 2007 Nov; 196(9):1346-54. PubMed ID: 17922399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
    Motlova J; Benes C; Kriz P
    Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance and the potential impact of pneumococcal conjugate vaccines.
    Dagan R
    Commun Dis Intell Q Rep; 2003; 27 Suppl():S134-42. PubMed ID: 12807290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric parapneumonic empyema: risk factors, clinical characteristics, microbiology, and management.
    Grisaru-Soen G; Eisenstadt M; Paret G; Schwartz D; Keller N; Nagar H; Reif S
    Pediatr Emerg Care; 2013 Apr; 29(4):425-9. PubMed ID: 23528501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empyema thoracis in Nigerians.
    Afonja AO; Sofowora EO
    Trop Geogr Med; 1972 Jan; 24(1):55-9. PubMed ID: 4400760
    [No Abstract]   [Full Text] [Related]  

  • 39. Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study.
    Langley JM; Kellner JD; Solomon N; Robinson JL; Le Saux N; McDonald J; Ulloa-Gutierrez R; Tan B; Allen U; Dobson S; Joudrey H
    BMC Infect Dis; 2008 Sep; 8():129. PubMed ID: 18816409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR; Good CE; Bajaksouzian S; Windau AR
    Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.